This week's View, guest hosted by Dr. Deepak Bhatt, investigates whether biomarkers can be used to identify subsets of patients post-acute coronary syndrome who would benefit best from adjunctive ezetimibe treatment, addresses the late results of mitral valve repair for mitral regurgitation due to mitral valve prolapse, and offers key points from the JACC Scientific Expert Panel opinion on the management of conduction disturbances associated with transcatheter aortic valve replacement.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Acute Coronary Syndrome, Arrhythmias, Cardiac, Atrial Fibrillation, Atrioventricular Block, Biomarkers, Bradycardia, Bundle-Branch Block, C-Reactive Protein, Cardiac Surgical Procedures, Death, Sudden, Defibrillators, Implantable, Dilatation, Echocardiography, Electrocardiography, Electrocardiography, Ambulatory, Electrophysiology, Endocarditis, Growth Differentiation Factor 15, Heart Block, Heart Failure, Heart Valve Diseases, Heart Valves, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Mitral Valve Insufficiency, Myocardial Infarction, Myocardial Ischemia, Natriuretic Peptide, Brain, Pacemaker, Artificial, Peptide Fragments, Prolapse, Reoperation, Risk Factors, Risk Reduction Behavior, Secondary Prevention, Simvastatin, Stroke, Stroke Volume, Telemetry, Thromboembolism, Transcatheter Aortic Valve Replacement, Tricuspid Valve Insufficiency, Troponin T, Anticoagulants, Dyslipidemias, Angiography, Coronary Angiography, Diagnostic Imaging

< Back to Listings